The SARS-CoV-2 (COVID-19) pandemic in hospital: An insight into environmental surfaces contamination, disinfectants’ efficiency, and estimation of plastic waste production

Abstract

The current COVID-19 pandemic that is caused by SARS-CoV-2 has led all the people around the globe to implement preventive measures such as environmental cleaning using alcohol-based materials, and social distancing in order to prevent and minimize viral transmission via fomites. The role of environmental surface contamination in viral transmission in within hospital wards is still debatable, especially considering the spread of new variants of the virus in the world. The present comprehensive study aims to investigate environmental surface contamination in different wards of a hospital as well as the efficacy of two common disinfectants for virus inactivation, and tries to produce an estimate of plastic residue pollution as an environmental side effect of the pandemic. With regard to environmental surface contamination, 76 samples were taken from different wards of the hospital, from which 40 were positive. These samples were taken from contaminated environmental surfaces such as patient bed handles, the nursing station, toilet door handles, cell phones, patient toilet sinks, toilet bowls, and patient's pillows, which are regularly-touched surfaces and can pose a high risk for transmission of the virus. The number of positive samples also reveals that SARS-CoV-2 can survive on inanimate surfaces after disinfection by ethanol 70 % and sodium hypochlorite (0.001 %). The results correspond to the time that the VOC 202012/01 (lineage B.1.1.7) had emerged in the hospital and this should be considered that this variant could possibly have different traits, characteristics, and level of persistence in the environment. The plastic waste as an environmental side effect of the pandemic was also investigated and it was confirmed that the amount of plastic residue for a single (RT) PCR confirmatory test for COVID-19 diagnosis is 821.778 g of plastic residue/test. As a result, it is recommended that for improving plastic waste management programs, considering challenges such as minimizing plastic waste pollution, optimization of gas control technologies in incinerators, process redesign, reduction of single-use plastics and PPE, etc. Is of utmost importance.

An analysis on the effect of coronavirus (COVID-19) pandemic movement control order (MCOS) on the solid waste generation in Peninsular Malaysia

“…While the plastic industry has historically capitalized on these issues (Prata et al 2020), recent concerns regarding COVID-19 protection have culminated in a reversal of policy to prohibit or limit SUP and fee payments in certain jurisdictions. Viable SARS-COV-2 virus survives longer on plastic surfaces than on other products, such as cardboard (Heidari et al 2019 ; Silva et al 2020 ; Noorimotlagh et al 2021 ); therefore, it may be claimed that rescinding SUP bans is premature, as many users have already adjusted to utilizing non-plastic substitutes following the introduction of these policies in many jurisdictions worldwide (Xanthos and Walker 2017 ; da Costa et al 2020 ). Furthermore, it is uncertain if reusable shopping bags could lead to a higher risk as opposed to clothing or shoes, a possible risk that could also be mitigated with better hand hygiene and a decontamination bath (i.e.…”

The COVID-19 pandemic reshapes the plastic pollution research – A comparative analysis of plastic pollution research before and during the pandemic

“…Sarkodie and Owusu assessed the impact of the COVID-19 epidemic on global waste management ( Sarkodie and Owusu, 2021 ). Vanapalli et al provided a forward-looking outlook on the damage caused by COVID-19 to global plastic waste management, and also proposed future directions and recommendations for inclusive and sustainable plastic waste management ( Faezeh et al, 2021 ; Vanapalli et al, 2021 ).…”

The Circulation of Common Respiratory Viruses and Their Co-infection with Severe Acute Respiratory Syndrome Coronavirus 2 Before and After Coronavirus Disease of 2019 Vaccination

“…It has been nearly two years since the onset of the COVID-19 pandemic by a new Coronavirus called SARS-CoV-2 that belongs to the Coronaviridae family. SARS-CoV-2 infection can cause a wide range of illnesses, from asymptomatic, mild symptoms such as fever, fatigue, dry cough, pain and bruising, nasal congestion, runny nose, sore throat, or some gastrointestinal manifestations, diarrhea, to serious problems such as pneumonia, and multiple organ dysfunction and even death (4,5). Since the onset of the pandemic in December 2020, approximately 5.5 million people have died of COVID-19, and more than 350 million infected cases have been reported (6).…”